课题基金 / 基金详情

A sex difference approach to evaluating resilience as a predictor of healthspan in mice

A sex difference approach to evaluating resilience as a predictor of healthspan in mice
评估弹性作为小鼠健康寿命预测因子的性别差异方法
批准号:
10166754
负责人:
STEVEN N. AUSTAD
金额:
$30.44万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-15 至 2023-05-31

项目摘要

项目成果

STEVEN N. AUSTAD的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结
英文摘要
Project Summary Aging of the human population has become the number one threat to human health globally as life expectancy is rising rapidly and because aging underlies nearly all major causes of death, disability, and degradation of the quality of later life. Hope for amelioration of this trend lies with the development of treatments that enhance and extend health. A major limitation on evaluating promising compounds for their senescence-inhibiting properties is the time it takes to perform lifespan studies in mice, the main preclinical animal model employed in biomedical research. Similarly, once compounds are ready for human testing, the time it takes to complete clinical trials will also become a bottleneck. In order to speed progress in the field then, it would be invaluable to develop a panel of short-term assays that could be administered to mice in early- to mid-life that would predict whether or not an intervention will extend healthspan in mice. The ability of an organism to recover from acute physical challenges or stresses is well-known to decline with age. If we define resilience as a quantitative metric which gauges the ability and speed of an organism to return to homeostasis after physical stress or challenge, then life- and health-extending interventions generally enhance resilience. The goal of the proposed research is to develop a standardized challenge or panel of challenges and their accompanying recovery metrics that will be informative about the healthspan impact of putative health-extending interventions when administered in early-to-mid life. The overarching hypothesis of the proposed research is that resilience assays can be developed that singly, or in combination, predict future life- and/or health-span. We propose to evaluate our overarching hypothesis purposely focusing on resilience assays with translational potential by performing the following specific aims (SAs). SA 1 will optimize resilience assay protocols, each consisting of an acute physical challenge and associated recovery metrics as to the best age and severity of challenge to use. SA 2 will determine whether the resilience assays optimized in specific aim 1 can identify the impact of known life- or health-span extension treatments. Three such treatments will be compared to untreated controls. These are: (a) dietary restriction (DR). This can be thought of as a positive control. To be informative, our resilience assays should predict longer life in both sexes; (b) rapamycin, our resilience assays should predict longer life in both sexes, but a greater effect in females; and (c) 17-α-estradiol. Our resilience assays should predict longer life in males only. SA 3 will evaluate the robustness of the most successful resilience assays identified in specific aim 2 across mouse genotypes. Because humans are so genetically and environmentally diverse, the generality of mouse assays should be maximized to the extent possible. Diverse mouse genotypes are available to access whether the assays developed in aim 2 are idiosyncratic to the original test genotype or robust as we would want for human trials.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Sex, mating and repeatability of Drosophila melanogaster longevity.
果蝇Melanogaster寿命的性别,交配和可重复性。
DOI: 10.1098/rsos.210273
发表时间: 2021-08
期刊: Royal Society open science
影响因子: 3.5
作者: [Hoffman JM, Dudeck SK, Patterson HK, Austad SN]
通讯作者: Austad SN
A New Translational Rat Model for Evaluating Anti-Aging Interventions
A New Translational Rat Model for Evaluating Anti-Aging Interventions
AIDS and Aging Research Platform (AARP)
  • 批准号:
    10683071
  • 项目类别:
  • 资助金额:
    $76.99万
  • 财政年份:
    2020
  • 负责人:
    STEVEN N. AUSTAD
  • 依托单位:
AIDS and Aging Research Platform (AARP)
  • 批准号:
    10330829
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    2020
  • 负责人:
    STEVEN N. AUSTAD
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: